These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 14978131)
1. Direct in vivo monitoring of acute allergic reactions in human conjunctiva. Helintö M; Renkonen R; Tervo T; Vesaluoma M; Saaren-Seppälä H; Haahtela T; Kirveskari J J Immunol; 2004 Mar; 172(5):3235-42. PubMed ID: 14978131 [TBL] [Abstract][Full Text] [Related]
2. Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. Ciprandi G; Buscaglia S; Pesce G; Villaggio B; Bagnasco M; Canonica GW J Allergy Clin Immunol; 1993 Mar; 91(3):783-92. PubMed ID: 8095941 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602 [TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone reduced in vivo, inflammation-induced slow rolling of leukocytes and their extravasation into human conjunctiva. Kirveskari J; Helintö M; Moilanen JA; Paavonen T; Tervo TM; Renkonen R Blood; 2002 Sep; 100(6):2203-7. PubMed ID: 12200386 [TBL] [Abstract][Full Text] [Related]
5. Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis. Nivenius E; Van der Ploeg I; Gafvelin G; Van Hage M; Montan PG Clin Exp Allergy; 2012 Jan; 42(1):58-65. PubMed ID: 22092652 [TBL] [Abstract][Full Text] [Related]
7. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793 [TBL] [Abstract][Full Text] [Related]
8. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Galatowicz G; Ajayi Y; Stern ME; Calder VL Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge. Fujishima H; Ohashi Y; Takamura E Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405 [TBL] [Abstract][Full Text] [Related]
10. The central role of conjunctival mast cells in the pathogenesis of ocular allergy. Leonardi A Curr Allergy Asthma Rep; 2002 Jul; 2(4):325-31. PubMed ID: 12044269 [TBL] [Abstract][Full Text] [Related]
11. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2. Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581 [TBL] [Abstract][Full Text] [Related]
13. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis. Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949 [TBL] [Abstract][Full Text] [Related]
14. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967 [TBL] [Abstract][Full Text] [Related]
15. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846 [TBL] [Abstract][Full Text] [Related]
16. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. Hylander T; Latif L; Petersson-Westin U; Cardell LO J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268 [TBL] [Abstract][Full Text] [Related]
17. Measurement of interleukin-4 and histamine in superficial cells of conjunctiva in patients with allergic conjunctivitis. Fujishima H; Saito I; Takeuchi T; Shinozaki N; Tsubota K Curr Eye Res; 1996 Feb; 15(2):209-13. PubMed ID: 8670730 [TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine. Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607 [TBL] [Abstract][Full Text] [Related]
19. Adhesion molecules and relationship to leukocyte levels in allergic eye disease. Bacon AS; McGill JI; Anderson DF; Baddeley S; Lightman SL; Holgate ST Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):322-30. PubMed ID: 9477989 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. Sperr WR; Agis H; Semper H; Valenta R; Susani M; Sperr M; Willheim M; Scheiner O; Liehl E; Lechner K; Valent P Int Arch Allergy Immunol; 1997 Sep; 114(1):68-73. PubMed ID: 9303333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]